D P Nichols - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

British Journal of Pharmacology|April 17, 2013

Nebulized thiocyanate improves lung infection outcomes in miceJ D Chandler, E Min, J Huang, et al.

Radiology|January 1, 1996

Functional bladder capacity measured during radionuclide cystography in childrenS T Treves, D Zurakowski, S B Bauer, et al.

Infection and Immunity|August 24, 1999

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotypeR B Parad, C J Gerard, D Zurakowski, et al.

AJR. American Journal of Roentgenology|November 3, 1998

Cystic fibrosis: predictors of accelerated decline and distribution of disease in 230 patientsR H Cleveland, A S Neish, D Zurakowski, et al.

AJR. American Journal of Roentgenology|April 8, 1998

Cystic fibrosis: a system for assessing and predicting progressionR H Cleveland, A S Neish, D Zurakowski, et al.

Endocrinology|September 1, 1996

Variable hormone responsiveness of osteoblast populations isolated at different stages of embryogenesis and its relationship to the osteogenic lineageL C Gerstenfeld, D Zurakowski, J L Schaffer, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 4, 2014

Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseaseJ L Taylor-Cousar, C Wiley, L A Felton, et al.

Journal of Diabetes Research|December 22, 2016

Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related DiabetesJ L Taylor-Cousar, J S Janssen, A Wilson, et al.

Thorax|June 21, 2013

Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosisJ A Nick, L A Sanders, B Ickes, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2020

Building global development strategies for cf therapeutics during a transitional cftr modulator eraN Mayer-Hamblett, S van Koningsbruggen-Rietschel, D P Nichols, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

British Journal of Pharmacology|April 17, 2013

Nebulized thiocyanate improves lung infection outcomes in miceJ D Chandler, E Min, J Huang, et al.

Radiology|January 1, 1996

Functional bladder capacity measured during radionuclide cystography in childrenS T Treves, D Zurakowski, S B Bauer, et al.

Infection and Immunity|August 24, 1999

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotypeR B Parad, C J Gerard, D Zurakowski, et al.

AJR. American Journal of Roentgenology|November 3, 1998

Cystic fibrosis: predictors of accelerated decline and distribution of disease in 230 patientsR H Cleveland, A S Neish, D Zurakowski, et al.

AJR. American Journal of Roentgenology|April 8, 1998

Cystic fibrosis: a system for assessing and predicting progressionR H Cleveland, A S Neish, D Zurakowski, et al.

Endocrinology|September 1, 1996

Variable hormone responsiveness of osteoblast populations isolated at different stages of embryogenesis and its relationship to the osteogenic lineageL C Gerstenfeld, D Zurakowski, J L Schaffer, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 4, 2014

Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseaseJ L Taylor-Cousar, C Wiley, L A Felton, et al.

Journal of Diabetes Research|December 22, 2016

Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related DiabetesJ L Taylor-Cousar, J S Janssen, A Wilson, et al.

Thorax|June 21, 2013

Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosisJ A Nick, L A Sanders, B Ickes, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2020

Building global development strategies for cf therapeutics during a transitional cftr modulator eraN Mayer-Hamblett, S van Koningsbruggen-Rietschel, D P Nichols, et al.

Pageof 1